Emlyn Samuel

Cancer Research UK
Head of Policy Development

Emlyn leads the policy development team at Cancer Research UK. His team is responsible for developing the charity''''s position on areas of public policy on a range of issues. This includes the how Government can support a thriving research environment, how cancer services are run - to diagnose patients earlier and provide better access to treatment - and how charity laws should be reformed.

His previous roles include policy positions at the Wellcome Trust, The Academy of Medical Sciences, and a secondment to the Office for Life Sciences to support the development of the Life Sciences Industrial Strategy.

dont miss

Brexit: getting the best outcome for research and patients

This seminar will discuss Cancer Research UK’s policy work on Brexit, including evidence about the impact of UK-EU collaboration and what our priorities are for negotiations about the future relationship between the UK and EU.

EVEN MORE SEMINARS

  • Mylaine Riobe MD, FABOIM, FACOG: Speaking at the Oncology Convention

    Mylaine Riobe MD, FABOIM, FACOG
    Riobe Institute of Integrative Medicine

    Cancer is not random! Evolving mechanisms for cancer causation and prevention

  • Dr Christy Goldsmith: Speaking at the Oncology Convention

    Dr Christy Goldsmith
    Action Radiotherapy

    Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)

  • Dr Shreerang Bhide: Speaking at the Oncology Convention

    Dr Shreerang Bhide
    Royal Marsden Hospital

    Circulating HPV DNA in Locally advanced head and neck cancer.

  • Nizar Asadi: Speaking at the Oncology Convention

    Nizar Asadi
    Royal Brompton & Harefield NHS Foundation Trust

    Thoracic surgery in the treatment of lung cancer

  • Professor A. Graham Pockley: Speaking at the Oncology Convention

    Professor A. Graham Pockley
    multimmune GmbH / Nottingham Trent University

    A new era of cancer therapeutics?